Trial Profile
Ezetimibe + moderate-dose simvastatin versus high-dose simvastatin in patients with coronary artery disease
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 24 Mar 2011
Price :
$35
*
At a glance
- Drugs Ezetimibe (Primary) ; Simvastatin (Primary)
- Indications Coronary artery disease
- Focus Pharmacodynamics
- 24 Mar 2011 New trial record